2019

IDIBELL and Sant Joan de Déu join efforts to create the first animal model of Sturge-Weber Syndrome

The project is led by Dr. Eulàlia Baselga, Area of Dermatology of the Hospital Sant Joan de Déu Barcelona, and Dr. Mariona Graupera, Bellvitge Biomedical Research Institute (IDIBELL). Its main objective is to identify a treatment aimed at reversing or improving the vascular alterations produced by the R183Q mutation in the GNAQ gene that leads to Sturge-Weber Syndrome.

IDIBELL and Sant Joan de Déu join efforts to create the first animal model of Sturge-Weber Syndrome Read More »

Innovation for value, the first international innovation conference at IDIBELL

On November 8, IDIBELL and ITEMAS co-organize Innovation for Value (#I4V), a conference focusing on the opportunities offered by innovation and new technologies in the healthcare field. In this event, which will take place at the Bellvitge University Hospital, speakers will also analyze the new business opportunities that arise thanks to scientific innovation and the

Innovation for value, the first international innovation conference at IDIBELL Read More »

A medicine for prostatic hyperplasia could help slow the progression of Parkinson’s disease

Parkinson’s disease (PD) is an old age disorder that causes a series of motor deficiencies that are characteristic. Normally, the four main symptoms are hand tremor, limb stiffness, slowness and impaired balance. With the progression of the disease, patients may also experience dementia and other neurological disorders. Since the main symptoms are due to degeneration

A medicine for prostatic hyperplasia could help slow the progression of Parkinson’s disease Read More »

The 2nd GRIN2B European Meeting brings together international experts and families suffering from this rare illness in Barcelona

The second GRIN2B European annual conference on GRINpathies, genetic defects of NMDA receptors, organized by the European Association GRIN2B, the group of Dr. Xavier Altafaj and collaborators of the Pompeu Fabra University and the Hospital Sant Joan de Déu, took place this past weekend. This meeting aims is to foster interactions between families, doctors and

The 2nd GRIN2B European Meeting brings together international experts and families suffering from this rare illness in Barcelona Read More »

Researchers prove the usefulness of semen miRNAs as non-invasive biomarkers for prostate cancer

Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Sara Larriba, in collaboration with Dr. Francesc Vigués and Dr. Manel Castells of the Urology Service of Bellvitge University Hospital (HUB), show the usefulness of certain molecules , the miRNAs in semen, as non-invasive biomarkers for prostate cancer.

Researchers prove the usefulness of semen miRNAs as non-invasive biomarkers for prostate cancer Read More »

Children’s brain recovers from stroke and acquires language abilities thanks to its plasticity

• In response to a stroke that affects the left hemisphere, children’s brains assign language functions to the right hemisphere • The study demonstrates our brain’s ability to reconnect in different ways, especially during early childhood

Children’s brain recovers from stroke and acquires language abilities thanks to its plasticity Read More »

Three IDIBELL researchers receive “la Caixa” Banking Foundation grants to carry out pioneering research projects with great social impact

Researchers Mariona Graupera, Gabriela Jiménez Valerio and Bárbara Rivera Polo of the Bellvitge Biomedical Research Institute (IDIBELL) have been awarded three grants of the “Scholarships and Grants for Research and Innovation 2019” program of the banking Foundation “la Caixa”, which were officially announced yesterday afternoon in an event chaired by Pedro Duque, Minister of Science,

Three IDIBELL researchers receive “la Caixa” Banking Foundation grants to carry out pioneering research projects with great social impact Read More »

Scroll to Top